Arvee Laboratories (India) Ltd. NSE: ARVEE

Arvee Laboratories (India) Ltd. Live Share Price Today, Share Analysis and Chart

149.44 -0.56 (-0.37%)

36.62% Fall from 52W High

82 NSE Volume

NSE 22 Apr, 2025 3:31 PM (IST)

Arvee Laboratories Key Metrics

Default
All financials are in INR Cr and price data in INR
VIEW MORE
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
High Financial Strength
75.0 / 100
Expensive Valuation
26.3 / 100
Technically Neutral
51.4 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

Arvee Laboratories Live Price Chart

Switch to TradingView
Fetching data ...

Arvee Laboratories Stock Analysis

Arvee Laboratories stock analysis with key metrics, changes, and trends.

Arvee Laboratories MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue₹30.99 Cr50.58%negative

Annual Revenue fell 50.58%, in the last year to ₹30.99 Cr. Its sector's average revenue growth for the last fiscal year was -10.35%.

Annual Net Profit₹1.05 Cr74.46%negative

Annual Net Profit fell 74.46% in the last year to ₹1.05 Cr. Its sector's average net profit growth for the last fiscal year was -45.78%.

Price to Earning Ratio75.05-negative

Price to Earning Ratio is 75.05, higher than its sector PE ratio of 51.17.

Stock Price₹149.44-33.73%negative

Stock Price fell 33.73% and underperformed its sector by 48.98% in the past year.

Quarterly Revenue₹9.1 Cr15.77%positive

Quarterly Revenue rose 15.77% YoY to ₹9.1 Cr. Its sector's average revenue growth YoY for the quarter was 10.58%.

Quarterly Net profit₹0.15 Cr34.93%negative

Quarterly Net profit fell 34.93% YoY to ₹0.15 Cr. Its sector's average net profit growth YoY for the quarter was 193.07%.

Debt to Equity Ratio0.03-positive

Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)3.61 %3.61%negative

Return on Equity(ROE) for the last financial year was 3.61%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.00 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 0%.

Promoter Share Holding73.50 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 73.5%.

Interest Coverage Ratio14.34-positive

Interest Coverage Ratio is 14.34, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Promoter Pledges0.00 %0%positive

Promoter Pledges are zero.

VIEW LESS


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

No documents available

Arvee Laboratories (India) Ltd. - Company Profile

What does Arvee Laboratories (India) Ltd. do?

Arvee Laboratories (India) is engaged in manufacturing of specialized chemicals.

Website: www.arveelabs.com

Arvee Laboratories (India) Ltd. Management structure

All Gross Remunerations are in INR
Mr. Saurin Gandhi
Chief Financial Officer
12.6 Lac
2024-3-31
Gross Remuneration
Year
Raina Singh Chauhan
Company Secretary, Compliance Officer
1.15 Lac
2024-3-31
Gross Remuneration
Year

Arvee Laboratories (India) Ltd. Board of directors

All Gross Remunerations are in INR
Shalin Sudhakarbhai Patel
Chairman & Managing Director
12 Lac
2020
Gross Remuneration
Year
Shalin Bharat Chokshi
Whole-time Director
12 Lac
2020
Gross Remuneration
Year
Chandrakala Ashok Bhatt
Independent Director
-
2020
Gross Remuneration
Year
Vishal Nitin Mehta
Independent Director
-
2020
Gross Remuneration
Year
Amishkumar Maheshkumar Shah
Independent Director
-
2020
Gross Remuneration
Year
Neetu Jalan
Independent Director
-
2020
Gross Remuneration
Year

Arvee Laboratories (India) Ltd. - company history

Arvee Laboratories (India) Limited was incorporated as a Private Limited Company with the name "Arvee Laboratories (India) Private Limited" on January 27, 2012 in Ahmedabad, Gujarat. Subsequently, the Company name was changed to Arvee Laboratories (India) Limited upon conversion into a Public Limited Company on September 19, 2017. Presently, the Company is engaged in manufacturing of specialized chemicals. Initially, the control & management of the Company was with Mr. Bharat Rasiklal Chokshi, Mr Saumil Bharatbhai Chokshi, Mr. Sudhakarbhai Chhotabhai Patel and Mr. Shalin Bharat Chokshi who were the subscribers to the Memorandum of Association. Since, April 01, 2013 the control & management was completely taken over by Mr. Shalin Sudhakarbhai Patel and Mr. Shalin Bharat Chokshi. The Company started construction of its first plant for Thiophene Derivatives in 2013. It acquired land, building and machineries from Skylink Chemicals Private Limited and started manufacturing unit. It commissioned the Thiophene Derivatives Plant in 2013. In 2014, the Company started construction of plant for Sulfo and Nitro Derivatives of Isophthalic Acid. In 2015, it commissioned the plant for Nitro Derivatives of Isophthalic Acid. In February 2018, the Company came up with a Public Issue of 14,60,000 Equity Shares by raising money through equity aggregating Rs 8.90 Crore. The vision of promoters, Mr. Shalin Bharat Chokshi and Mr. Shalin Sudhakarbhai Patel aims at diversifying the activity of manufacturing specialty chemicals like Dimethyl 5-Nitroisphthalate, 2-ThiopheneCarboxaldehyde, 2-Acetyl Thiophene, Lithium Sulpho Isopthalic Acid-LiSIPA, etc that cater to the needs and demands of other businesses in India and overseas. The diversification into other chemicals are based on the yield that a particular chemical is providing by leading to low wastage and high effectiveness. Arvee has established its credibility as an approved vendor in the international market after successfully passing the Quality Audits conducted by various companies of international repute. The plant facilities and other utility services at Arvee are equipped to undertake a host of processes namely: Nitration, Sulfonation, Reduction, Esterification, Hoffman Reaction, Caustic Fusion, etc.

Arvee Laboratories (India) Ltd. FAQ

How is Arvee Laboratories (India) Ltd. today?
Arvee Laboratories (India) Ltd. today is trading in the red, and is down by -0.37% at 149.44.
Arvee Laboratories (India) Ltd. is currently trading down -0.37% on an intraday basis. In the past week the stock rose 4.08%. stock has been down -4.25% in the past quarter and fell -33.73% in the past year. You can view this in the overview section.